Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Sales (2016 - 2025)

Historic Return on Sales for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Nephros' Return on Sales rose 200.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.01% for FY2024, which is 1200.0% up from last year.
  • Nephros' Return on Sales amounted to 0.07% in Q3 2025, which was up 200.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, Nephros' Return on Sales peaked at 0.12% during Q1 2025, and registered a low of 0.79% during Q3 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.09% (2024), whereas its average is 0.13%.
  • In the last 5 years, Nephros' Return on Sales tumbled by -6500bps in 2022 and then soared by 7400bps in 2023.
  • Nephros' Return on Sales (Quarter) stood at 0.12% in 2021, then soared by 57bps to 0.05% in 2022, then tumbled by -279bps to 0.19% in 2023, then surged by 149bps to 0.09% in 2024, then fell by -25bps to 0.07% in 2025.
  • Its Return on Sales stands at 0.07% for Q3 2025, versus 0.05% for Q2 2025 and 0.12% for Q1 2025.